Appropriateness of antiviral prescribing for influenza in ambulatory care: A retrospective analysis

Read full text Summarise with VIRAT
Authors: Savera Ikram Arain, Suhaj Abdulsalim, Fahad Khalawi, Hassan S. AlHamad, Shabeer Ali Thorakkattil, Mohammed Saif Anaam, Hind Nasser AlSuwaidan, Marwa Abdullah AL Dhamen, Ali H. Al‐Homoud
Cited by: 0
References: 40

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Problem considered In order to prevent antiviral resistance and lessen influenza-related complications oseltamivir must be used promptly and appropriately. However, evidence suggests that oseltamivir is still under-prescribed in high-risk ambulatory care populations. This raises the need to evaluate prescribing patterns and determine adherence to established evidence-based recommendations. Methods This retrospective study included 196 ambulatory patients prescribed oseltamivir between January and December 2023. Data, including demographics, clinical indication, therapy duration, dosing, PCR results, vaccination status, comorbidities, and concurrent antibiotic use, were extracted from charts. Appropriateness of prescribing was evaluated based on the Infectious Diseases Society of America stewardship guidelines. Data analysis was performed using SPSS version 25. Results Of the 196 patients prescribed oseltamivir, 65.3% were aged ≤15 years, and 51% were female. Influenza PCR was performed in 45.4% of patients, with 28.1% testing positive for Influenza A. Only 11.7% had received a flu vaccine in the past year; 7 of 23 vaccinated patients were diagnosed with influenza. Fever occurred in 70.4% of cases, and 21.4% had comorbidities, 42.8% of whom were asthmatic. Oseltamivir was prescribed every 12 hours in 99% of the patients, with 97% receiving a 5-day course. A hospital revisit was required in 18% of the patients. Conclusion These findings emphasize a substantial influenza burden among ambulatory patients and highlight gaps in diagnostic testing and vaccination acceptance. Oseltamivir was appropriately prescribed in most patients. Further research on diversifying testing protocols, expanding vaccine coverage, and regional influenza epidemiology is needed to inform clinical and public health practice.

Fields of Study & Subjects

Influenza Virus Research Studies Antibiotic Use and Resistance Pneumonia and Respiratory Infections

Publication details

Journal / source
Clinical Epidemiology and Global Health
Volume
39
Pages
102353–102353
Publication date
27 March 2026
Language
EN